Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: lynne.nichols@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://cmu.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Contract for the supply of low dose diphtheria, tetanus and inactivated polio vaccine.
Reference number: CM/PHV/12/5352
II.1.2) Main CPV code
33651600
II.1.3) Type of contract
Supplies
II.1.4) Short description
Procurement exercise for a contract for the supply of a low dose diphtheria, tetanus and inactivated polio vaccine.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Bedford, UK.
II.2.4) Description of the procurement
The provision of low dose diphtheria, tetanus and inactivated polio vaccine (Td/IPV), to be used as part of the national childhood immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 4,600,00 doses of vaccine.
The opportunity is not being split into lots as there is only one supplier that holds a marketing authorisation for this product.
II.2.5) Award criteria
Quality criterion: Available on request if required
/ Weighting: Available on request
Cost criterion: Available on request if required
/ Weighting: Available on request
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2016/S 190-340290
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
02/12/2016
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Sanofi Pasteur MSD Ltd
Mallards Reach, Bridge Avenue
Maidenhead
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The contract(s) is for the benefit of the Contracting Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
Runcorn
UK
VI.5) Date of dispatch of this notice
20/12/2016